Close Menu

NEW YORK ─ Luminex said after the close of the market on Tuesday that its second-quarter revenues rose 32 percent year over year, driven by COVID-19-related sales, in line with preliminary revenues reported in July.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.